F5 Inc

FFIV remains in a Stage 2 advancing regime undergoing a corrective reset, with price bouncing off the rising 50 DMA. The medium-term bias is bullish, but short-term EMAs are sloping down and price is pulling back into the EMA zone without exhaustion, so we defer execution for a pullback acceptance into the 9/21 EMA and 50 DMA support area.

• ↑Q2 revenue $812M up 11% YoY; product revenue +22% for seventh straight quarter.
• ↑Record free cash flow of $348M supports reinvestment and $522M share repurchase plan.
• ↓Negative earnings yield and weak growth factors indicate potential value trap.